SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1702<i>I'd also say the heparin contamination issue also raises the probabDewDiligence_on_SI-4/28/2008
1701<i>demonstrate an ability to make/keep their product safe?</i> OnlyBiomaven-4/28/2008
1700>>Ultimately it is all about safety. True. Doesn't MNTA's capabiIRWIN JAMES FRANKEL-4/28/2008
1699No way. Ultimately it is all about safety. I have been exiting very hard over Robohogs-4/28/2008
1698I suppose there's a lot of politics involved but the FDA may be more friendlidos-4/28/2008
1697Notable calls on this morning's Morgan Stanley upgrade: notablecalls.blogsptuck-4/28/2008
1696This was foreshadowed by MS putting MNTA on review last week: MNTA: Upgraded thIRWIN JAMES FRANKEL-4/28/2008
1695MNTA director Elizabeth Stoner is now on the BoD of MBRX: biz.yahoo.com It doeDewDiligence_on_SI-4/25/2008
1694<i>I hate these 10b5-1 plans and wish the SEC would ban them.</i> Mhmpa-4/24/2008
1693>>I’m much more interested in insider holdings and transactions than in inIRWIN JAMES FRANKEL-4/24/2008
1692In general, I’m much more interested in insider holdings and transactions than iDewDiligence_on_SI-4/24/2008
1691Agree But then Visium added, got up to 2.3M in early March from 0.5M 12/31. ijIRWIN JAMES FRANKEL-4/24/2008
1690SVP John Bishop sold 9,375 shares today at $13 pursuant to his 10b5-1 plan: secDewDiligence_on_SI-4/24/2008
1689SI flat at 5.1MIRWIN JAMES FRANKEL-4/24/2008
1688<i>>…brownie points at the FDA…<</i> These could come in handDewDiligence_on_SI-4/24/2008
1687<i>Does this, to a certain extent, validate mnta's characterization meBiomaven-4/24/2008
1686Does this , to a certain extent , validate mnta's characterization method ?osofun-4/24/2008
1685no message!keokalani'nui-4/24/2008
1684Been a black hole unfortunately.rkrw-4/24/2008
1683rkrw- Pertinent to your post, are you aware of any public statement by Lilly Biotech Jim-4/24/2008
1682RPM Report April 2008, Vol. 3, No. 10 Big Pharma May Be Big Player in Follow-Orkrw-4/24/2008
1681Will MNTA be required to add over-sulphated chondroitin sulphate to its generic DewDiligence_on_SI-4/24/2008
1680Amazing and so fast. Maybe the UK will want to rethink this: UK warns on imprkrw-4/24/2008
1679LOLDewDiligence_on_SI-4/24/2008
1678>For some reason, your quotation marks came out as question marks.< Sorryidos-4/24/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News